Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Ketoconazole Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Ketoconazole Oral
  • 1.4.3 Ketoconazole Topical
  • 1.4.4 Ketoconazole Shampoo
• 1.5 Market by Application
  • 1.5.1 Global Ketoconazole Market Share by Application (2014-2025)
  • 1.5.2 Antifungal
  • 1.5.3 Non-fungal conditions
  • 1.5.4 Hair Loss
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Ketoconazole Market Size
• 2.2 Ketoconazole Growth Trends by Regions
  • 2.2.1 Ketoconazole Market Size by Regions (2014-2025)
  • 2.2.2 Ketoconazole Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Ketoconazole Market Size by Manufacturers
  • 3.1.1 Global Ketoconazole Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Ketoconazole Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Ketoconazole Market Concentration Ratio (CR5 and HHI)
• 3.2 Ketoconazole Key Players Head office and Area Served
• 3.3 Key Players Ketoconazole Product/Solution/Service
• 3.4 Date of Enter into Ketoconazole Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Ketoconazole Market Size by Type (2014-2019)
• 4.2 Global Ketoconazole Market Size by Application (2014-2019)

5 United States

• 5.1 United States Ketoconazole Market Size (2014-2019)
• 5.2 Ketoconazole Key Players in United States
• 5.3 United States Ketoconazole Market Size by Type
• 5.4 United States Ketoconazole Market Size by Application

6 Europe

• 6.1 Europe Ketoconazole Market Size (2014-2019)
• 6.2 Ketoconazole Key Players in Europe
• 6.3 Europe Ketoconazole Market Size by Type
• 6.4 Europe Ketoconazole Market Size by Application

7 China

• 7.1 China Ketoconazole Market Size (2014-2019)
• 7.2 Ketoconazole Key Players in China
• 7.3 China Ketoconazole Market Size by Type
• 7.4 China Ketoconazole Market Size by Application

8 Japan

• 8.1 Japan Ketoconazole Market Size (2014-2019)
• 8.2 Ketoconazole Key Players in Japan
• 8.3 Japan Ketoconazole Market Size by Type
• 8.4 Japan Ketoconazole Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Ketoconazole Market Size (2014-2019)
• 9.2 Ketoconazole Key Players in Southeast Asia
• 9.3 Southeast Asia Ketoconazole Market Size by Type
• 9.4 Southeast Asia Ketoconazole Market Size by Application

10 India

• 10.1 India Ketoconazole Market Size (2014-2019)
• 10.2 Ketoconazole Key Players in India
• 10.3 India Ketoconazole Market Size by Type
• 10.4 India Ketoconazole Market Size by Application

11 Central & South America

• 11.1 Central & South America Ketoconazole Market Size (2014-2019)
• 11.2 Ketoconazole Key Players in Central & South America
• 11.3 Central & South America Ketoconazole Market Size by Type
• 11.4 Central & South America Ketoconazole Market Size by Application

12 International Players Profiles

• 12.1 Mylan
  • 12.1.1 Mylan Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Ketoconazole Introduction
  • 12.1.4 Mylan Revenue in Ketoconazole Business (2014-2019)
  • 12.1.5 Mylan Recent Development
• 12.2 Almirall
  • 12.2.1 Almirall Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Ketoconazole Introduction
  • 12.2.4 Almirall Revenue in Ketoconazole Business (2014-2019)
  • 12.2.5 Almirall Recent Development
• 12.3 j&j
  • 12.3.1 j&j Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Ketoconazole Introduction
  • 12.3.4 j&j Revenue in Ketoconazole Business (2014-2019)
  • 12.3.5 j&j Recent Development
• 12.4 Taro Pharmaceutical
  • 12.4.1 Taro Pharmaceutical Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Ketoconazole Introduction
  • 12.4.4 Taro Pharmaceutical Revenue in Ketoconazole Business (2014-2019)
  • 12.4.5 Taro Pharmaceutical Recent Development
• 12.5 Teva Pharmaceutical
  • 12.5.1 Teva Pharmaceutical Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Ketoconazole Introduction
  • 12.5.4 Teva Pharmaceutical Revenue in Ketoconazole Business (2014-2019)
  • 12.5.5 Teva Pharmaceutical Recent Development
• 12.6 SANDOZ
  • 12.6.1 SANDOZ Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Ketoconazole Introduction
  • 12.6.4 SANDOZ Revenue in Ketoconazole Business (2014-2019)
  • 12.6.5 SANDOZ Recent Development
• 12.7 Strides Pharma
  • 12.7.1 Strides Pharma Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Ketoconazole Introduction
  • 12.7.4 Strides Pharma Revenue in Ketoconazole Business (2014-2019)
  • 12.7.5 Strides Pharma Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Ketoconazole is an antifungal medication which is used primarily to treat fungal infections. Ketoconazole is sold commercially as a tablet for oral administration (although this use has been discontinued in a number of countries), and in a variety of formulations for topical administration, such as creams (used to treat tinea; cutaneous candidiasis, including candidal paronychia; and pityriasis versicolor) and shampoos (used primarily to treat dandruff – seborrhoeic dermatitis of the scalp).
In 2018, the global Ketoconazole market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ketoconazole status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ketoconazole development in United States, Europe and China.

The key players covered in this study
Mylan
Almirall
j&j
Taro Pharmaceutical
Teva Pharmaceutical
SANDOZ
Strides Pharma
...

Market segment by Type, the product can be split into
Ketoconazole Oral
Ketoconazole Topical
Ketoconazole Shampoo

Market segment by Application, split into
Antifungal
Non-fungal conditions
Hair Loss

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ketoconazole status, future forecast, growth opportunity, key market and key players.
To present the Ketoconazole development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ketoconazole are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.